Harvest Fund Management Co., LTD Tg Therapeutics, Inc. Transaction History
Harvest Fund Management Co., LTD
- $1.66 Billion
- Q3 2024
A detailed history of Harvest Fund Management Co., LTD transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 4,761 shares of TGTX stock, worth $150,685. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,761Holding current value
$150,685% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
339Shares Held
88.5MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$487 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$360 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$288 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$113 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$101 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.6B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...